BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 2350628)

  • 1. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients.
    Katsanis E; Shapiro RS; Robison LL; Haake RJ; Kim T; Pescovitz OH; Ramsay NK
    Bone Marrow Transplant; 1990 May; 5(5):335-40. PubMed ID: 2350628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation.
    Boulad F; Bromley M; Black P; Heller G; Sarafoglou K; Gillio A; Papadopoulos E; Sklar C
    Bone Marrow Transplant; 1995 Jan; 15(1):71-6. PubMed ID: 7742758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth in children following irradiation for bone marrow transplantation.
    Bushhouse S; Ramsay NK; Pescovitz OH; Kim T; Robison LL
    Am J Pediatr Hematol Oncol; 1989; 11(2):134-40. PubMed ID: 2665547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning.
    Slatter MA; Gennery AR; Cheetham TD; Bhattacharya A; Crooks BN; Flood TJ; Cant AJ; Abinun M
    Bone Marrow Transplant; 2004 May; 33(9):949-53. PubMed ID: 15004542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment results of bone marrow transplantation in Kyushu Cancer Center. Bone Marrow Transplantation Team].
    Tasaka H; Ikuno Y; Okamura J
    Rinsho Ketsueki; 1990 Mar; 31(3):315-9. PubMed ID: 2366334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center.
    Gaziev D; Giardini C; Galimberti M; Lucarelli G; Angelucci E; Polchi P; Baronciani D; Erer B; Sotti G
    Bone Marrow Transplant; 1999 Aug; 24(3):253-7. PubMed ID: 10455362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia.
    Berger C; Le-Gallo B; Donadieu J; Richard O; Devergie A; Galambrun C; Bordigoni P; Vilmer E; Plouvier E; Perel Y; Michel G; Stephan JL
    Bone Marrow Transplant; 2005 May; 35(10):991-5. PubMed ID: 15806126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation for the treatment of haematological disorders in Down's syndrome: toxicity and outcome.
    Rubin CM; Mick R; Johnson FL
    Bone Marrow Transplant; 1996 Sep; 18(3):533-40. PubMed ID: 8879614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
    Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
    Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractionated total body irradiation plus high-dose VP-16 prior to allogeneic bone marrow transplantation in children with poor risk acute leukaemias.
    Suttorp M; Schmitz N; Leuschner S; Appelt M; Rister M; Schaub J
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():144-8. PubMed ID: 2697428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid function in children after allogeneic bone marrow transplantation.
    Borgström B; Bolme P
    Bone Marrow Transplant; 1994 Jan; 13(1):59-64. PubMed ID: 8019454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
    Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J
    Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.
    Hernández-Boluda JC; Marín P; Carreras E; Aguilar JL; Grañena A; Rozman C; Montserrat E
    Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults.
    Kauppila M; Koskinen P; Irjala K; Remes K; Viikari J
    Bone Marrow Transplant; 1998 Aug; 22(4):331-7. PubMed ID: 9722067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T; Kojima S; Kato K
    Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
    Cuthbert RJ; Shepherd JD; Nantel SH; Barnett MJ; Reece DE; Klingemann HG; Chan KW; Spinelli JJ; Sutherland HJ; Phillips GL
    Clin Invest Med; 1995 Apr; 18(2):122-30. PubMed ID: 7788957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants.
    Al-Fiar FZ; Colwill R; Lipton JH; Fyles G; Spaner D; Messner H
    Bone Marrow Transplant; 1997 May; 19(10):1019-22. PubMed ID: 9169646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
    Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.